4
|
Gan X, Zhou F, Xu T, Liu X, Zhang R, Zheng Z, Yang X, Zhou X, Yu F, Li J, Cui R, Wang L, Yuan J, Yao D, Becker B. A neurofunctional signature of subjective disgust generalizes to oral distaste and socio-moral contexts. Nat Hum Behav 2024; 8:1383-1402. [PMID: 38641635 DOI: 10.1038/s41562-024-01868-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/29/2023] [Accepted: 03/19/2024] [Indexed: 04/21/2024]
Abstract
While disgust originates in the hard-wired mammalian distaste response, the conscious experience of disgust in humans strongly depends on subjective appraisal and may even extend to socio-moral contexts. Here, in a series of studies, we combined functional magnetic resonance imaging with machine-learning-based predictive modelling to establish a comprehensive neurobiological model of subjective disgust. The developed neurofunctional signature accurately predicted momentary self-reported subjective disgust across discovery (n = 78) and pre-registered validation (n = 30) cohorts and generalized across core disgust (n = 34 and n = 26), gustatory distaste (n = 30) and socio-moral (unfair offers; n = 43) contexts. Disgust experience was encoded in distributed cortical and subcortical systems, and exhibited distinct and shared neural representations with subjective fear or negative affect in interoceptive-emotional awareness and conscious appraisal systems, while the signatures most accurately predicted the respective target experience. We provide an accurate functional magnetic resonance imaging signature for disgust with a high potential to resolve ongoing evolutionary debates.
Collapse
Affiliation(s)
- Xianyang Gan
- The Center of Psychosomatic Medicine, Sichuan Provincial Center for Mental Health, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China
- Clinical Hospital of Chengdu Brain Science Institute, MOE Key Laboratory for Neuroinformation, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, China
| | - Feng Zhou
- Faculty of Psychology, Southwest University, Chongqing, China
| | - Ting Xu
- The Center of Psychosomatic Medicine, Sichuan Provincial Center for Mental Health, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China
- Clinical Hospital of Chengdu Brain Science Institute, MOE Key Laboratory for Neuroinformation, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, China
| | - Xiaobo Liu
- McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada
| | - Ran Zhang
- The Center of Psychosomatic Medicine, Sichuan Provincial Center for Mental Health, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China
- Clinical Hospital of Chengdu Brain Science Institute, MOE Key Laboratory for Neuroinformation, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, China
| | - Zihao Zheng
- The Center of Psychosomatic Medicine, Sichuan Provincial Center for Mental Health, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China
- Clinical Hospital of Chengdu Brain Science Institute, MOE Key Laboratory for Neuroinformation, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, China
| | - Xi Yang
- Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, the Netherlands
| | - Xinqi Zhou
- Sichuan Key Laboratory of Psychology and Behavior of Discipline Inspection and Supervision, Institute of Brain and Psychological Sciences, Sichuan Normal University, Chengdu, China
| | - Fangwen Yu
- The Center of Psychosomatic Medicine, Sichuan Provincial Center for Mental Health, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China
- Clinical Hospital of Chengdu Brain Science Institute, MOE Key Laboratory for Neuroinformation, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, China
| | - Jialin Li
- Max Planck School of Cognition, Leipzig, Germany
| | - Ruifang Cui
- The Center of Psychosomatic Medicine, Sichuan Provincial Center for Mental Health, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China
- Clinical Hospital of Chengdu Brain Science Institute, MOE Key Laboratory for Neuroinformation, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, China
| | - Lan Wang
- The Center of Psychosomatic Medicine, Sichuan Provincial Center for Mental Health, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China
- Clinical Hospital of Chengdu Brain Science Institute, MOE Key Laboratory for Neuroinformation, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, China
| | - Jiajin Yuan
- Sichuan Key Laboratory of Psychology and Behavior of Discipline Inspection and Supervision, Institute of Brain and Psychological Sciences, Sichuan Normal University, Chengdu, China
| | - Dezhong Yao
- The Center of Psychosomatic Medicine, Sichuan Provincial Center for Mental Health, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China
- Clinical Hospital of Chengdu Brain Science Institute, MOE Key Laboratory for Neuroinformation, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, China
| | - Benjamin Becker
- The Center of Psychosomatic Medicine, Sichuan Provincial Center for Mental Health, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
- Clinical Hospital of Chengdu Brain Science Institute, MOE Key Laboratory for Neuroinformation, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, China.
- State Key Laboratory for Brain and Cognitive Sciences, The University of Hong Kong, Hong Kong, China.
- Department of Psychology, The University of Hong Kong, Hong Kong, China.
| |
Collapse
|
7
|
Levine SM, Merz K, Keeser D, Kunz JI, Barton BB, Reinhard MA, Jobst A, Padberg F, Neukel C, Herpertz SC, Bertsch K, Musil R. Altered amygdalar emotion space in borderline personality disorder normalizes following dialectical behaviour therapy. J Psychiatry Neurosci 2023; 48:E431-E438. [PMID: 37935476 PMCID: PMC10635707 DOI: 10.1503/jpn.230085] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/29/2023] [Revised: 07/24/2023] [Accepted: 09/05/2023] [Indexed: 11/09/2023] Open
Abstract
BACKGROUND Borderline personality disorder (BPD) is a mental health condition characterized by an inability to regulate emotions or accurately process the emotional states of others. Previous neuroimaging studies using classical univariate analyses have tied such emotion dysregulation to aberrant activity levels in the amygdala of patients with BPD. However, multivariate analyses have not yet been used to investigate how representational spaces of emotion information may be systematically altered in patients with BPD. METHODS Patients with BPD performed an emotional face matching task while undergoing MRI before and after a 10-week inpatient program of dialectical behavioural therapy. Representational similarity analysis (RSA) was applied to activity patterns (evoked by angry, fearful, neutral and surprised faces) in the amygdala and temporo-occipital fusiform gyrus of patients with BPD and in the amygdala of healthy controls. RESULTS We recruited 15 patients with BPD (8 females, 6 males, 1 transgender male) to participate in the study, and we obtained a neuroimaging data set for 25 healthy controls for a comparative analysis. The RSA of the amygdala revealed a negative bias in the underlying affective space (in that activity patterns evoked by angry, fearful and neutral faces were more similar to each other than to patterns evoked by surprised faces), which normalized after therapy. This bias-to-normalization effect was present neither in activity patterns of the temporo-occipital fusiform gyrus of patients nor in amygdalar activity patterns of healthy controls. LIMITATIONS Larger samples and additional questionnaires would help to better characterize the association between specific aspects of therapy and changes in the neural representational space. CONCLUSION Our findings suggest a more refined role for the amygdala in the pathological processing of perceived emotions and may provide new diagnostic and prognostic imaging-based markers of emotion dysregulation and personality disorders.Clinical trial registration: DRKS00019821, German Clinical Trials Register (Deutsches Register Klinischer Studien).
Collapse
Affiliation(s)
- Seth M Levine
- From the Department of Psychology, LMU Munich, Munich, Germany (Levine, Bertsch); the NeuroImaging Core Unit Munich (NICUM), University Hospital, LMU Munich, Munich, Germany (Levine, Merz, Keeser, Bertsch); the Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany (Merz, Keeser, Kunz, Barton, Reinhard, Jobst, Padberg, Musil); the Department of General Psychiatry, Center for Psychosocial Medicine, Heidelberg University, Heidelberg, Germany (Neukel, Herpertz, Bertsch); and the German Center for Mental Health (DZPG), Munich, Germany (Padberg, Bertsch)
| | - Katharina Merz
- From the Department of Psychology, LMU Munich, Munich, Germany (Levine, Bertsch); the NeuroImaging Core Unit Munich (NICUM), University Hospital, LMU Munich, Munich, Germany (Levine, Merz, Keeser, Bertsch); the Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany (Merz, Keeser, Kunz, Barton, Reinhard, Jobst, Padberg, Musil); the Department of General Psychiatry, Center for Psychosocial Medicine, Heidelberg University, Heidelberg, Germany (Neukel, Herpertz, Bertsch); and the German Center for Mental Health (DZPG), Munich, Germany (Padberg, Bertsch)
| | - Daniel Keeser
- From the Department of Psychology, LMU Munich, Munich, Germany (Levine, Bertsch); the NeuroImaging Core Unit Munich (NICUM), University Hospital, LMU Munich, Munich, Germany (Levine, Merz, Keeser, Bertsch); the Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany (Merz, Keeser, Kunz, Barton, Reinhard, Jobst, Padberg, Musil); the Department of General Psychiatry, Center for Psychosocial Medicine, Heidelberg University, Heidelberg, Germany (Neukel, Herpertz, Bertsch); and the German Center for Mental Health (DZPG), Munich, Germany (Padberg, Bertsch)
| | - Julia I Kunz
- From the Department of Psychology, LMU Munich, Munich, Germany (Levine, Bertsch); the NeuroImaging Core Unit Munich (NICUM), University Hospital, LMU Munich, Munich, Germany (Levine, Merz, Keeser, Bertsch); the Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany (Merz, Keeser, Kunz, Barton, Reinhard, Jobst, Padberg, Musil); the Department of General Psychiatry, Center for Psychosocial Medicine, Heidelberg University, Heidelberg, Germany (Neukel, Herpertz, Bertsch); and the German Center for Mental Health (DZPG), Munich, Germany (Padberg, Bertsch)
| | - Barbara B Barton
- From the Department of Psychology, LMU Munich, Munich, Germany (Levine, Bertsch); the NeuroImaging Core Unit Munich (NICUM), University Hospital, LMU Munich, Munich, Germany (Levine, Merz, Keeser, Bertsch); the Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany (Merz, Keeser, Kunz, Barton, Reinhard, Jobst, Padberg, Musil); the Department of General Psychiatry, Center for Psychosocial Medicine, Heidelberg University, Heidelberg, Germany (Neukel, Herpertz, Bertsch); and the German Center for Mental Health (DZPG), Munich, Germany (Padberg, Bertsch)
| | - Matthias A Reinhard
- From the Department of Psychology, LMU Munich, Munich, Germany (Levine, Bertsch); the NeuroImaging Core Unit Munich (NICUM), University Hospital, LMU Munich, Munich, Germany (Levine, Merz, Keeser, Bertsch); the Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany (Merz, Keeser, Kunz, Barton, Reinhard, Jobst, Padberg, Musil); the Department of General Psychiatry, Center for Psychosocial Medicine, Heidelberg University, Heidelberg, Germany (Neukel, Herpertz, Bertsch); and the German Center for Mental Health (DZPG), Munich, Germany (Padberg, Bertsch)
| | - Andrea Jobst
- From the Department of Psychology, LMU Munich, Munich, Germany (Levine, Bertsch); the NeuroImaging Core Unit Munich (NICUM), University Hospital, LMU Munich, Munich, Germany (Levine, Merz, Keeser, Bertsch); the Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany (Merz, Keeser, Kunz, Barton, Reinhard, Jobst, Padberg, Musil); the Department of General Psychiatry, Center for Psychosocial Medicine, Heidelberg University, Heidelberg, Germany (Neukel, Herpertz, Bertsch); and the German Center for Mental Health (DZPG), Munich, Germany (Padberg, Bertsch)
| | - Frank Padberg
- From the Department of Psychology, LMU Munich, Munich, Germany (Levine, Bertsch); the NeuroImaging Core Unit Munich (NICUM), University Hospital, LMU Munich, Munich, Germany (Levine, Merz, Keeser, Bertsch); the Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany (Merz, Keeser, Kunz, Barton, Reinhard, Jobst, Padberg, Musil); the Department of General Psychiatry, Center for Psychosocial Medicine, Heidelberg University, Heidelberg, Germany (Neukel, Herpertz, Bertsch); and the German Center for Mental Health (DZPG), Munich, Germany (Padberg, Bertsch)
| | - Corinne Neukel
- From the Department of Psychology, LMU Munich, Munich, Germany (Levine, Bertsch); the NeuroImaging Core Unit Munich (NICUM), University Hospital, LMU Munich, Munich, Germany (Levine, Merz, Keeser, Bertsch); the Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany (Merz, Keeser, Kunz, Barton, Reinhard, Jobst, Padberg, Musil); the Department of General Psychiatry, Center for Psychosocial Medicine, Heidelberg University, Heidelberg, Germany (Neukel, Herpertz, Bertsch); and the German Center for Mental Health (DZPG), Munich, Germany (Padberg, Bertsch)
| | - Sabine C Herpertz
- From the Department of Psychology, LMU Munich, Munich, Germany (Levine, Bertsch); the NeuroImaging Core Unit Munich (NICUM), University Hospital, LMU Munich, Munich, Germany (Levine, Merz, Keeser, Bertsch); the Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany (Merz, Keeser, Kunz, Barton, Reinhard, Jobst, Padberg, Musil); the Department of General Psychiatry, Center for Psychosocial Medicine, Heidelberg University, Heidelberg, Germany (Neukel, Herpertz, Bertsch); and the German Center for Mental Health (DZPG), Munich, Germany (Padberg, Bertsch)
| | - Katja Bertsch
- From the Department of Psychology, LMU Munich, Munich, Germany (Levine, Bertsch); the NeuroImaging Core Unit Munich (NICUM), University Hospital, LMU Munich, Munich, Germany (Levine, Merz, Keeser, Bertsch); the Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany (Merz, Keeser, Kunz, Barton, Reinhard, Jobst, Padberg, Musil); the Department of General Psychiatry, Center for Psychosocial Medicine, Heidelberg University, Heidelberg, Germany (Neukel, Herpertz, Bertsch); and the German Center for Mental Health (DZPG), Munich, Germany (Padberg, Bertsch)
| | - Richard Musil
- From the Department of Psychology, LMU Munich, Munich, Germany (Levine, Bertsch); the NeuroImaging Core Unit Munich (NICUM), University Hospital, LMU Munich, Munich, Germany (Levine, Merz, Keeser, Bertsch); the Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany (Merz, Keeser, Kunz, Barton, Reinhard, Jobst, Padberg, Musil); the Department of General Psychiatry, Center for Psychosocial Medicine, Heidelberg University, Heidelberg, Germany (Neukel, Herpertz, Bertsch); and the German Center for Mental Health (DZPG), Munich, Germany (Padberg, Bertsch)
| |
Collapse
|
8
|
Rupprecht R, Pradhan AK, Kufner M, Brunner LM, Nothdurfter C, Wein S, Schwarzbach J, Puig X, Rupprecht C, Rammes G. Neurosteroids and translocator protein 18 kDa (TSPO) in depression: implications for synaptic plasticity, cognition, and treatment options. Eur Arch Psychiatry Clin Neurosci 2023; 273:1477-1487. [PMID: 36574032 DOI: 10.1007/s00406-022-01532-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/17/2022] [Accepted: 11/30/2022] [Indexed: 12/28/2022]
Abstract
There is need for novel fast acting treatment options in affective disorders. 3α-reduced neurosteroids such as allopregnanolone are powerful positive allosteric modulators of GABAA receptors and target also extrasynaptic receptors. Their synthesis is mediated by the translocator protein 18 kDa (TSPO). TSPO ligands not only promote endogenous neurosteroidogenesis, but also exert a broad spectrum of functions involving modulation of mitochondrial activity and acting as anti-inflammatory and neuroregenerative agents. Besides affective symptoms, in depression cognitive impairment can be frequently observed, which may be ameliorated through targeting of extrasynaptic GABAA receptors either via TSPO ligands or exogenously administered 3α-reduced neurosteroids. Interestingly, recent findings indicate an enhanced activation of the complement system, e.g., enhanced expression of C1q, both in depression and dementia. It is of note that benzodiazepines have been shown to reduce long-term potentiation and to cause cognitive decline. Intriguingly, TSPO may be crucial in mediating the effects of benzodiazepines on synaptic pruning. Here, we discuss how benzodiazepines and TSPO may interfere with synaptic pruning. Moreover, we highlight recent developments of TSPO ligands and 3α-reduced neurosteroids as therapeutic agents. Etifoxine is the only clinically available TSPO ligand so far and has been studied in anxiety disorders. Regarding 3α-reduced neurosteroids, brexanolone, an intravenous formulation of allopregnanolone, has been approved for the treatment of postpartum depression and zuranolone, an orally available 3α-reduced neurosteroid, is currently being studied in major depressive disorder and postpartum depression. As such, 3α-reduced neurosteroids and TSPO ligands may constitute promising treatment approaches for affective disorders.
Collapse
Affiliation(s)
- Rainer Rupprecht
- Department of Psychiatry and Psychotherapy, University Regensburg, Universitätsstrasse 84, 93053, Regensburg, Germany.
| | - Arpit Kumar Pradhan
- Experimental Neuropharmacology, Department of Anesthesiology, Technical University Munich, Munich, Germany
| | - Marco Kufner
- Department of Psychiatry and Psychotherapy, University Regensburg, Universitätsstrasse 84, 93053, Regensburg, Germany
| | - Lisa Marie Brunner
- Department of Psychiatry and Psychotherapy, University Regensburg, Universitätsstrasse 84, 93053, Regensburg, Germany
| | - Caroline Nothdurfter
- Department of Psychiatry and Psychotherapy, University Regensburg, Universitätsstrasse 84, 93053, Regensburg, Germany
| | - Simon Wein
- Department of Psychiatry and Psychotherapy, University Regensburg, Universitätsstrasse 84, 93053, Regensburg, Germany
| | - Jens Schwarzbach
- Department of Psychiatry and Psychotherapy, University Regensburg, Universitätsstrasse 84, 93053, Regensburg, Germany
| | - Xenia Puig
- Experimental Neuropharmacology, Department of Anesthesiology, Technical University Munich, Munich, Germany
| | - Christian Rupprecht
- Experimental Neuropharmacology, Department of Anesthesiology, Technical University Munich, Munich, Germany
| | - Gerhard Rammes
- Experimental Neuropharmacology, Department of Anesthesiology, Technical University Munich, Munich, Germany
| |
Collapse
|